To further confirm that IP6K2 is involved in glioma progression, stable lentivirus-mediated IP6K2 overexpressing U87 cells or LV-transfected U87 cells were used for tumor formation in immunodeficient mice. This evidence concerns the gene IP6K2 and glioma.